Retinoblastoma gene harbors a large spectrum of pathogenic variants, around 2500 discovered so far, with more than 500 different somatic or germline mutations resulting in RB1 inactivation (RetNet; https://sph.uth.edu/retnet/). This evidence concerns the gene RB1 and retinoblastoma.